Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
Authors
Keywords
Idiopathic pulmonary fibrosis, Bleomycin, Sulforaphane, Epithelial-mesenchymal transition
Journal
BMC Pharmacology & Toxicology
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-04
DOI
10.1186/s40360-018-0204-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Idiopathic pulmonary fibrosis
- (2017) Luca Richeldi et al. LANCET
- Sulforaphane prevents bleomycin-induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2-related factor-2 activation
- (2017) Bingdi Yan et al. Molecular Medicine Reports
- Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
- (2017) Soorya P. Illam et al. Recent Patents on Anti-Cancer Drug Discovery
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
- (2013) Yang Bai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Nuclear Factor Erythroid 2-Related Factor 2 Nuclear Translocation Induces Myofibroblastic Dedifferentiation in Idiopathic Pulmonary Fibrosis
- (2012) Elise Artaud-Macari et al. ANTIOXIDANTS & REDOX SIGNALING
- Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells
- (2012) Yujuan Shan et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Transforming Growth Factor-β and Nuclear Factor E2–related Factor 2 Regulate Antioxidant Responses in Airway Smooth Muscle Cells
- (2011) Charalambos Michaeloudes et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Attenuation of Transforming Growth Factor–β–Stimulated Collagen Production in Fibroblasts by Quercetin-Induced Heme Oxygenase–1
- (2011) Toshinobu Nakamura et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Modeling pulmonary fibrosis with bleomycin
- (2011) Marios A. Mouratis et al. CURRENT OPINION IN PULMONARY MEDICINE
- Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling
- (2011) Chang Joo Oh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- Role of Endoplasmic Reticulum Stress in Epithelial–Mesenchymal Transition of Alveolar Epithelial Cells
- (2010) Qian Zhong et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Pharmacokinetics and Pharmacodynamics of Broccoli Sprouts on the Suppression of Prostate Cancer in Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mice: Implication of Induction of Nrf2, HO-1 and Apoptosis and the Suppression of Akt-dependent Kinase Pathway
- (2009) Young-Sam Keum et al. PHARMACEUTICAL RESEARCH
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
- (2007) Antje Moeller et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation